Clinical proof-of-concept results with a novel TRPA1 antagonist (LY3526318) in 3 chronic pain states. Mellado Lagarde MM, Wilbraham D, Martins RF, Zhao HS, et al. Pain 2024 Dec 13. doi: 10.1097/j.pain.0000000000003487.

Read + Share

Amedeo Smart

Independent Medical Education

Mellado Lagarde MM, Wilbraham D, Martins RF, Zhao HS, et al. Clinical proof-of-concept results with a novel TRPA1 antagonist (LY3526318) in 3 chronic pain states. Pain 2024 Dec 13. doi: 10.1097/j.pain.0000000000003487.
PMID: 39679712